The bill establishes a new section, 627.42398, in the Florida Statutes that sets cost-sharing requirements for diabetes management. It defines key terms such as "cost-sharing requirement," "diabetes device," and "diabetic ketoacidosis device." The legislation prohibits health insurance policies from imposing a cost-sharing requirement that exceeds $35 for a 30-day supply of insulin, regardless of the quantity or type prescribed, and $100 for a 30-day supply of any diabetes device or diabetic ketoacidosis device.

This new regulation will apply to all health insurance policies delivered, issued, renewed, or amended on or after January 1, 2027, and includes various types of health insurers and organizations. The act is set to take effect on July 1, 2026.